Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Impilo on the establishment of Impilo Healthcare
Mandate

Vinge advises Impilo on the establishment of Impilo Healthcare

July 01, 2025 Private Funds

Vinge has advised Impilo with regulatory advice on the establishment of Impilo Healthcare. The fund will have EUR 320m in commitments.

Impilo is a Nordic investment company focused solely on investments in lower-mid market Nordic healthcare companies across the pharmaceuticals, MedTech, specialist pharma services and other healthcare and related services industries. Impilo has a well-diversified portfolio of healthcare investments and manages approximately EUR 2 billion of capital from leading international investors.

Vinges team consisted of Nils Unckel, Anton Sjökvist, Viktoria Wnuk and Isabelle Asserståhl.

Related

Vinge advises Triton in connection with the acquisition of Prenax

 Vinge has advised Triton Smaller Mid Cap Fund II in connection with the acquisition of Prenax from LBO France and certain minority shareholders.
July 01, 2025

Vinge advises KEYTO Group in connection with the acquisition of Enspecta

 KEYTO Group continues its growth journey by strengthening its offering in Sweden as Enspecta joins the group. This strategic addition marks KEYTO’s entry into a new service vertical focused on home inspection, assessment and optimisation - and reinforces the ambition of a leading, tech-enabled one-stop destination for home-related services. 
July 01, 2025

Vinge has advised Terranor Group AB in connection with its listing on Nasdaq First North Growth Market

 Vinge has advised Terranor Group AB (publ) (“Terranor”) connection with its listing on Nasdaq First North Growth Market. The first day of trading in Terranor's shares is today 30 June 2025.
June 30, 2025